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Abstract. A series of site-specific insertion and dele-
tion mutants was prepared in the pro domain of trans-
forming growth factor ,Q1 (TGFa1) encoded by simian
TGF01 cDNA. These mutants were transiently ex
pressed in COS-1 cells and the ability of each to be
properly processed, folded correctly, and secreted was
determined by immunoblot analysis of cells and cul-
ture supernatants. Insertions in regions corresponding
to amino acid residues 50, 154, and 170 blocked secre-
tion ; culture supernatants from COS-1 cells showed no
immunologically reactive proteins, whereas intact cells
contained high levels of the mutant polypeptides. In-
sertions in the middle portion of the pro domain at
residues 81, 85, and 144 affected disulfide maturation
of the mature TGFOL An insertion at residue 110, on
T
RANSFORMING growth factor-beta-I (TGF#I)' is a
potent regulator of cell growth and differentiation
(Roberts and Sporn, 1988, 1990; Barnard et al., 1990).
Following the initial purification and characterization of
TGFQI as a homodimeric, 24-kD polypeptide (Assoian et
al., 1983; Frolik et al ., 1983 ; Roberts et al ., 1983), several
distinct but related TGF# family members have been cloned
and analyzed by cDNA sequencing (Derynck et al ., 1985,
1988; deMartin et al., 1987; ten-Dijke et al ., 1988; Hanks
et al ., 1988; Jakowlew et al., 1988a,b; Madisen et al .,
1988), indicating that they share similar structural proper-
ties. These novel TGFos are encoded as large precursors and
each is processed from the carboxyl-terminus of its precur-
sor by proteolytic cleavage. The mature TGFas all show con-
siderable sequence similarity (-80%) and contain nine cys-
teine residues which can be perfectly aligned in sequence.
The pro domains ofeach precursor contain three aligned cys-
teine residues as well as several sites for N-linked glycosyla-
tion. Since the pro portions of each precursor show less se-
quence similarity (<50%), each form of the growth factor
may be secreted and activated differently.
Studies on posttranslational modification and processing
of the TGF01 precursor have been derived from sequence
1. Abbreviations used in this paper: LAP, latency-associated peptide;
TGF01, transforming growth factor 01.
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the other hand, appeared to destabilize the mature
TGF01 polypeptide, resulting in degraded growth fac-
tor. Relatively small (10 amino acids) to large (125
amino acids) deletion mutations in the pro domain of
TGF0I, when expressed as the full-length pre-pro-
TGF/01, appeared to block secretion. By contrast, if
the pro domain (designated al-latency-associated pep-
tide [a1-LAP]) was expressed independently, deletion
mutants in the region 40-110 were readily secreted by
the COS-1 cells, whereas deletions in residues 110-210
either destabilized the structure of the protein or blocked
its intracellular transport. Cross-linking assays employ-
ing radioiodinated TGF01 and biological assays indi-
cate that residues 50-85 of (31-LAP are required for
association with mature TGFOL
analysis of cDNA clones (Derynck et al., 1985, 1986; Shar-
ples et al., 1987)and from the high-level expression ofthese
proteins in CHO cells (Gentry et al., 1987, 1988, 1989);
these studies have indicated that a signal sequence of 29
amino acids is removed from the amino-terminus between
Gly-29/Leu-30 (Gentry et al., 1988). Glycosylation occurs
at all three predicted N-linked siteswithin the pro region fol-
lowed by phosphorylation at mannose residues of the at-
tached oligosaccharides (Purchio et al., 1988 ; Brunner et
al., 1988). At some stage during synthesis or transit, proteo-
lytic cleavage at dibasic residues and disulfide bond forma-
tion occur and the mature growth factor is released (Gentry
et al., 1988). The precise order of the processing, and the
pathway of the intracellular routine of TGF01 precursor have
not been characterized.
The independently expressed pro domain of TGF01, when
cotransfected with the mature TGF,61, aids in the folding of
the growth factor within the cell resulting in a small percent-
age of secreted, mature TGF01 (Gray and Mason, 1990).
Furthermore, the pro portion of TGFf1 represents a func-
tional binding protein for mature TGF01 (Gentry et al.,
1987; Miyazomo et al., 1988; Wakefield et al., 1989; Gentry
and Nash, 1990). The dimer of this pro domain, termed /31-
latency-associated peptide ((31-LAP), appears to be impor-
tant for its biological function (Brunner et al., 1989; Gentry
and Nash, 1990). The resulting latent form may then be acti-
827vated by extreme pH values, by heat, or by treatment with
selected chaotropic agents or proteases (Lawrence et al.,
1985 ; Pircher et al., 1986; Lyons et al., 1988, 1990; Gentry
and Nash, 1990). These results suggest that the TGFOI pro
domain serves an important role in disulfide folding of ma-
ture TGFfl and latent complex formation.
As an initial step towards understanding the mechanisms
by which cells control TGF01 activities, we undertook a sys-
tematic dissection of the pro domain of TGFOI by site-
specific insertion and deletion mutagenesis. Our approach
was to place a unique 12-mar oligonucleotide at specific re-
striction sites in the pro domain of TGF01, resulting in the
in-frame placement of four amino acids. Such insertions
should disrupt the local protein structure and allow our as-
signment of functional regions. The mutant TGFM mole-
cules were transfected in COS-1 cells and the proteins were
identified by immunoblotting and then analyzed for proteo-
lytic processing, secretion, and disulfide maturation. We
foundby these approaches that the structural integrity of the
pro region, when expressed as pre-pro-TGFOI, is essential
for secretory exit of mature and precursor forms of TGFOI
from cells. Several insertions resulted in mutants of TGF,81
precursors which were not secreted, whileinsertions at other
sites resulted in high levels of disulfide-linked TGFOI ag-
gregates, indicating that mature TGFOI was not properly
folded at disulfide bonds. Independently expressed deletion
mutants of al-LAP reveal that the amino-terminal portion of
the pro region is involved in noncovalent association of the
mature TGFOI to form a latent complex.
Materials and Methods
CellCulture Condition
COS-1 cells (ATCC CRL 1650), a simian fibroblast cell line transformed
by an origin-defective mutant ofSV40, andminklung epithelial cells (ATCC
CCL 64) were grown in DMEM supplemented with FBS (10% vol/vol),
penicillin (100 U/ml), and streptomycin (100 pg/ml) . These cells were pas-
saged by treatment with 0.5 % (wt/vol) trypsin (Gibco Laboratories, Grand
Island, NY) at a 1:5 splitting ratio.
Mutagenesis
Thebasicstrategy used to construct aseries ofin-phase linker insertion mu-
tations in thepro regionofTGFftl peptide wasbased on the methodofStone
et al. (1984). The pUC19-TGFSI vector DNA was linearized at RsaI, Alul,
or BstUI restriction sites in the pro domain of TGFOI by employing
ethidium bromide to limit the restriction endonuclease cleavage reaction
(Stone et al., 1984) . The nonphosphorylated dodecanucleotide linkers 5'-
d(GGAAGATCTTCC) were inserted into the linear DNA by linker tailing
(Lathe et al., 1984), resulting in the insertion of only one oligonucleotide
linker specifying a unique BglII recognition sequence. The insertion muta-
tions resulted in the in-frame placement of four amino acids within the cod-
ing region ofthe precursor ofTGFSl. Out of a total of 13 restriction sites,
we prepared 12 insertion mutants throughout the pro region of TGFM. The
insertion mutants were designated In, followed by the position of the first
codon containing nucleotide derived from the inserted oligomer. These in-
sertion mutants and amino acid changes due to the insertions are shown in
Fig. 1 and Table I. All plasmids carrying a single Bg1II linker in the coding
region ofthe pro domain of TGF$1 were sequenced (Sanger and Coulson,
1975) to confirm the position of the linker and the integrity ofthe TGF01
precursor mutants.
The insertion mutant cDNAs were placed into the expression vector
pCDM8 (Seed, 1987). This vector contains an SV40 origin of replication
which allows for high copy numbers of plasmid molecules in COS-1 cells.
Furthermore, transcription of the mutant pre-pro-TGFSl cDNAs is con-
trolled by thepowerful CMV promoter, apromoterthat functionsquite well
in monkey fibroblasts (Seed, 1987). The pUC19-TGFO1 mutant DNA was
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digested with EcoRl and the overhang was filled inwithKlenow DNA poly-
merase. This blunt end DNA was digested withHindHI andthe 1.4-kb frag-
ments were isolated from an agarose gel. The expression vector pCDM8
(Seed, 1987) was cut with Nod, filled in with Klenow DNA polymerase,
and then digested with HindIII. The HindIII to EcoRI (blunt) fragment of
pre-pro-TGFOI mutant was ligated into the pCDM8 vector.
Theplacement ofunique restriction sites within the precursor of TGFfl1
cDNA allowed for the creation of in-frame deletion mutants by using pairs
of insertion mutants. Pairs with Bg1II linkers inserted in the same reading
frame were directly recombined by ligating the appropriate fragments iso-
lated after digestion ofplasmid with both Bg1II and HindIII. In-frame dele-
tions between Bg1II sites thatwere not inthe proper reading frame required
either digestion with single strand-specific mung bean nuclease or were
filled in withthe Klenow DNA polymeraseand ligated. In all cases, ligation
ofends produced by BgIII digestionand treatment with mung bean nuclease
generates unique EcoRl sites which could be used for screening mini-
preparation DNA samples. The recombinant plasmids bearing deletions at
different sites were identified, mapped by restriction enzyme analysis,
and/or sequenced. The deletion mutants expressing pre-pro-TGF#l were
identified by A followed by the positions of the two insertion mutants used
for their construction (see Table l1).
To prepare deletion mutants which express the pro region independent
of the mature TGFfll, the plasmid pCDM8-Stop278 was utilized (Gentry
and Nash, 1990). Each deletion mutant cDNA was excised from its respec-
tive pCDM8 expression vector with HindIII and BstXI and used to replace
the wild-type sequence of the pro domain of TGFS1 in the plasmid vector
pCDM8-Stop278. These deletion mutants expressing the pro domain in-
dependently were named as 01-LAP deletion mutants, and designated L,
followed by the same definition as previously described for the pre-pro-
TGF/31 deletion mutants (see Table II).
Tlransient Expression
The pCDM8 constructs containing the mutant genes were transfected into
COS-1 cells by a modified DEAE-dextran/chloroquine method (Seed and
Aruffo, 1987). Each transfection was repeated at least three times. COS-1
cells .,,ere plated onto 10-cm plates and transfected at 30-60% confluence.
After a briefincubation with DME containing 10% Nu-serum (Collabora-
tive Research, Lexington, MA), 50 kg of DNA in a total volume of 5 ml
(DME/Nu-serum) was added to each plate for 2.5 h. After further incuba-
tion of the cells for 48 h in DME supplemented with 10% FBS, the medium
was changedto serum-free DME (5 ml/10-cmdish) and collected after48 h.
Each experiment included control plates containing cells transfected by
pCDM8 and pCDM8-TGFSI or pCDM8-Stop278. The transfected cells
were washed three times with cold PBS, scraped from the culture plate in
cold PBS, and collected by low-speed centrifugation.
ImmunoblotAnalysis
Secreted and cellular forms of the precursor for TGFOI were analyzed by
immunoblotting (Gentry et al., 1987). Serum-free conditioned medium was
collected at the end of transfection. PMSF was added to the medium at a
final concentration of 1 mM, which was then clarified by low-speed cen-
trifugation. The medium was then dialyzed against 0.2 M acetic acid and
1-ml aliquots were lyophilized. Each lyophilized sample was resuspended
in20 ul ofsample preparation buffer and fractionated on 7.5-17.5 % gradient
or 12% SDS-polyacrylamide gels (Laemmli, 1970). The cells were lysed
with equal volume of 2x sample preparation buffer and heated at 95°C for
4 min before analysis. After electrophoresis, proteins were electrophoreti-
cally transferred to nitrocellulose and stained for inununoreactive mature
and precursor forms ofthe TGF01 proteins as described previously (Gentry
et al., 1987). The antisera used were directed against residues 225-236 of
the pro portion of TGFs1 or residues 369-381 of the mature growth factor
(see Fig. 3) . In some experiments, affinity-purified antipeptide antibodies
were utilized for immunostaining.
Affinity-purified antipeptide antibodies were prepared using the proce-
dure described by Smith and Fisher (1984). Briefly, concentrated culture su-
pernatants from CHO cells expressing high levels of rTGFpl precursor
(Gentry et al., 1987) were fractionated by SDS-polyacrylamide gels and
transferred to nitrocellulose membranes. The protein bands corresponding
to the mature and pro region ofTGF0I were visualized after the membrane
was stained with 0.5% ponceau S, excised, and incubated overnight with
the antipeptide antiserum, respectively. The antibodies were eluted with
0.1 M glycine-HCI, 0.1 M NaCl (pH 2.5), and immediately neutralized
with 1 M Tris-HCI, pH 8.0. Alkaline phosphatase-conjugated-Protein A or
828alkaline phosphatase-conjugated, affinity-purified goat anti-rabbit IgG
(Cappel, West Chester, PA) was utilized for antigen detection .
Quantitation ofMature andPrecursorForms
ofTGFa1
The levels of mature TGFl1 monomers and the 44-56-kD precursor forms
(Fig . 3 C, forma and c, respectively), as well as mature TGF,6I dimers and
the disulfide aggregates (Fig. 3 B, form A and C, respectively) in culture
supernatants were measured by densitometer scanning ofthe immunoblots .
The relative amounts of mature TGF01 monomers (Fig . 3 C) and dimers
(Fig . 3 B) in the culture medium were expressed as a percentage ofthat ob-
served from wild-type, pCDM8-TGFO1 transfections (Table I) . To measure
effects ondisulfide formationof mature TGFOI from pre-pro-TGFO1 and the
various mutants, theA and C values from nonreducing gels measured above
(Fig . 3 B) were manipulated by the following formula, [C/(A+C)] x 100,
and will be referred to as disulfide folding percentage (see text) (seeTable 1) .
Digestion with N-Glycanase
Conditioned culture medium (1 ml) was lyophilized and suspended in 10
mM ethylenediaminetetraacetic acid, 0.2 % SDS, 0.1 M2-mercaptoethanol,
and I% NP-40 (pH 7.5) . Digestion was performed at 30°C overnight using
1.25 U N-glycanase (Genzyme, Boston, MA) . After digestion, the samples
were mixed with an equal volume of 2x SDS-gel buffer and analyzed on
immunoblots .
Growth InhibitionAssay
Mink lung epithelial cells were utilized for growth inhibition assay of
TGFOI and its mutant precursors . The assay was performed using a
modified procedure combining a method described previously (Ikeda et al .,
1987) and a colorimetric assay to assess cell proliferation (Mosmann,
1983) . A colorless tetrazolium salt (3-(4,5-dimethylthiazol-2-yl)-2,5-di-
phenyl) tetrazolium bromide (Sigma Chemical Co ., St. Louis, MO) is con-
verted to a colored product by the cells and the optical density at 590 nm
Figure 1. Insertion and deletion mutations in the pro region of
TGF01 used in this study . The HindIII to EcoRl fragmentof simian
pre-pro-TGFO1 was the substrate for insertion mutagenesis. For ref-
erence, the SstII restriction sites are noted . The open bar represents
the coding region of the pro domain of TGF/61 . The dotted bar and
the hatched bar indicate signal peptide and mature TGF01 coding
region, respectively . Asterisks denote the N-linked glycosylation
sites . The Arg codon (CGA) is replaced by a stop codon (7GA) for
expression of (31-LAP independently. The restriction site BstXI
used in construction of ,Q1-LAP deletion mutants is shown in the
above diagram . The position of each Bg1II linker is shown in the
bottom diagram and is indicated by the arrows above the open bar.
The solid bars located below the plane ofthe figure shows the dele-
tion regions made. For reference, the distance for 100 by is indi-
cated in the above diagram .
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is proportional to the number of living cells. Serum-free supernatants con-
taining mature TGFfl1 or its precursor mutants were concentrated threefold
by ultrafiltration (YM10 membrane, 10,000 molecular weight cutoff; Ami-
con Corp ., Danvers, MA), heated for 5 min at 85°C, and diluted in com-
plete medium . Samples were added to mink lung cells in 96-well microtiter
dishes in triplicate . After incubation of the cells for 72 h at 37°C in a hu-
midified 5 % COi atmosphere, the incubation media was removed, tetrazo-
lium salt was addedto each well (50 IAI at 0.83 mg/ml incompletemedium),
and the cells were further incubated at 37°C for 0.5 h . Dimethyl sulfoxide
(50 )Al) was added to each well, the plates were shaken, and the amount of
colored product was determined with a Dynatech MR 580 Microelisa
reader at 590nM . The use of standard amounts ofmature TGFflI indicated
that 3-4 pM inhibited cell growth by 50% .
Cross-Linkingof01-LAPand ItsMutants
to Radioiodinated TGFOI
Carrier-free, mature TGFOI was purchased from R & D systems (Min-
neapolis, MN) and labeled with Na' 25I (Amersham Corp ., Arlington
Heights, IL) by using chloramineT as described previously (Ruff and Riz-
zino, 1986) . The radioiodinated TGFfI was biologically active and had a
specific activity of 55 pCi/14g. Cross-linking experiments were performed
as described previously (Gentry and Nash, 1990) . The amounts of pro re-
gion dimer of TGFOI in the supernatants from cells transfected by Stop278
and 01-LAP deletion mutants were determined by densitometer scanning
the immunoblot (see Fig . 6 A) . Control medium (2 pl) containingpCDM8
vector or Stop278, or an equivalent amount of medium containing 01-LAP
mutant proteins was added to a total reaction volume of 20 ul, including
2 pl of radioiodinated TGFOI (170,000 dpm) . After cross-linking and after
SDS-PAGE, the protein bands were excised and the amount of iodinated
cross-linking product was measured in a -y-counter . Nonspecific binding
was determined using equivalent amounts of medium from cells transfected
with pCDM8 and was <20% .
Results
Construction ofa Series ofInframeInsertion
andDeletion Mutations in thePro Region ofTGF01
PrecursorSequence
Our general approach was mutational dissection of the pro
region of the TGFOI precursor to investigate the structural
features that are important in posttranslational events such as
proteolytic processing, disulfide bridge formation, protein
secretion and latent complex formation . Linker insertional
mutagenesis has been successfully used to study functional
domains within the v-fps (Stone et al ., 1984), glucocorticoid
receptor (Giguere et al., 1986), c-myc (Stone et al ., 1987),
v-fms (Lyman et al., 1987), and HSV 1 (Hardwicke et al .,
1989) . This type of mutagenesis provides evenly distributed
in-frame insertion ofseveral amino acids throughout the pro-
tein coding region by introducing synthetic oligonucleotide
linkers at specific restriction sites. The inserted amino acids
should disrupt the local protein structure and allow for iden-
tification of functional domains of the proteins .
The sites of linker insertion in the pro region are shown
in Fig . 1 and listed in Table I . Restriction sites that were used
for mutant construction and the amino acid codons that were
inserted are also shown here (Table I) . Four different amino
acid insertions were possible from the above restriction sites,
depending on what mRNA reading frame the insertion oc-
curred . Insertion ofGRSS and EDLP were considered "true
insertions" since they were placed between original amino
acid residues, whereas insertion of WKIFH and REDLP
changed one amino acid of the coding sequence oftheTGFOI
precursor.
A set of site-specific, in-frame deletion mutants which
comprehensively covers the pro region coding sequence was
829Table L TGFl31 Insertion Mutants
* In parentheses are the inserted amino acids, whereas original codons are shown outside. Amino acids appearing below the plane are deleted due to insertional
interruption.
t The immunoblot run under reducing conditions (shown in Fig. 3 C) was quantitated by densitometry as described in Materials and Methods. The amounts of
12-kD monomeric TGFO1 (form c) in the supernatants are expressed as a percentage of wild-type TGFS1 (CDM8-TGFS1).
if The amounts of mature TGFO1 dimer were quantitated by densitometer scanning of the nonreducing immunoblot shown in Fig. 3 B (form C) and expressed
as a percentage of wild-type TGFQ1 (CDM8-TGFOI).
II The amounts of bioactive TGF$ secreted by COS-1 cell transfectants were determined as described in Materials and Methods. Wild-type TGFO1 produced -70
ng/ml active TGF/3. The results were expressed as a percentage of wild-type activity f standard deviation (CDM8-TGFO1) . Results are based on six independent
determinations.
I The immunoreactive disulfide complex (form A) and the mature TGFQ1 dimer (form C) shown in Fig. 3 B were quantitated by densitometry as described in
Materials and Methods. Thedisulfide folding percentage shown isbased on the following equation, [C/(A+C)] x 100, using the results obtained from densitometer
scanning. A disulfide folding percentage of 20 for wild-type, pre-pro-TGFOI is similar to results obtained from CHO cells expressing large amounts of rTGF31
and its precursors (unpublished observations). For more information see Results section.
also prepared (Table II) ; it covers the whole sequence of the
pro region in blocks from 10 to 125 residues. Some of the
deletions were designed to encompass one, two, or all three
potential glycosylation signals in the pro region.
pCDM8 vectors containing insertion mutants in the precur-
sor of TGFfI were transiently expressed in COS-1 cells. As
controls, the pCDM8 vector itself without an insert and
pCDM8 containing a wild-type, pre-pro-TGFOl cDNA
(pCDM8-TGFM) were used as controls. After transfection,
the cells and the serum-free supernatants from the trans-
fected cells were analyzed by Western blot analysis using ei-
ther mature TGFO1 specific or pro region-specific antibod-
ies (Gentry et al., 1987). Immunoblotting was necessary
since these antibodies do not recognize the native protein and
can not be used for immunoprecipitation analysis.
Effects ofthe Insertion Mutations in the
Pro Region ofTGF01 on Synthesis, Proteolytic
Processing, Disulfide Maturation, and Secretion of
Mature TGFf1 Pblypeptides
Fig. 2 shows an immunoblotof cells transfected by pre-pro-
TGF,0ll and its insertion mutants. Proteins were electropho-
resed under reducing conditions and the blot was incubated
with serum against mature TGF01 followed by staining with
alkaline phosphatase-conjugated Protein A . The pCDM8
control transfection showed no immunoreactive TGF01 pre-
cursors. In all other cases, however, the precursor of TGF,61
and its insertion mutants were readily expressed in COS-1
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cells and produced proteins possessing molecular masses of
-44 kD (Fig. 2). These results indicate that wild-type and
insertion mutants of the TGFOI precursors were expressed
by COS-1 cellsand that steady-state levels ofthe intracellular
mutant pre-pro-TGFOls were comparable to that of wild-
type. The intracellular form of the TGF01 precursor proba-
bly represents the partially glycosylated pro-TGFOI, as ob-
served previously in CHO cells expressing high levels of
rTGF01 precursor (Sha et al., 1989) . Use of alkaline phos-
phatase-conjugated goat anti-rabbit IgG for staining resulted
in greater sensitivity, and consistently showed the existence
of mature TGFO1 in the intact cells transfected with wild-
type, pre-pro-TGFSI (see Fig. 4 B) .
An immunoblot of serum-free media from each of the
transfectants is shown in Fig. 3 B. Under nonreducing condi-
tion of electrophoresis, peptide-specific antiserum against
mature TGFO1 identified a 100-120-kD protein, and a 24-
kD protein in medium from cells transfected with wild-type,
pre-pro-TGFO1 (pCDM8TGFO1). These immunoreactive
forms comigrated with rTGF0l precursors produced by
CHO cells, suggesting that the high molecular weight band
probably represented a complex of the pro-TGF01 (form a),
the pro region (form b) and the mature TGF01 (form c)
linked by intersubunit disulfide bonds. The low molecular
weight band corresponds to mature TGFOI dimer (Gentry et
al ., 1987, 1988). These forms were not present in the super-
natants from cells transfected with pCDM8 vector. Mutants
In50, In110, In154, and In170 showed no immunostainable
levels of mature or larger molecular mass forms of TGFO1
830
Insertion
mutants
Restriction
sites
mutated
Codons
inserted*
Secreted
TG/3I monomer
(% of
wild-type)t
Secreted
TGFOI dimer
(% of
wild-type)§
Biologically
active TGFO
(% of
wild-type)II
Disulfide
folding
percentage)
CDM8 2 7 8.0 t 2.0 ND
CDM8-TGF/31 100 100 100 t 11 .3 20
1n40 AM E(GRSS)L 59 88 46.8 t 3 .5 30
In50 BstUI R(EDLP)G 3 6 10.0 t 2 .9 ND
In81 RsaI L(WKIFH)N 33 13 9 .0 f 1 .8 5
Y
In85 BstUI R(EDLP)E 31 14 9.7 f 2 .0 6
1n110 BstUI R(EDLP)V 7 4 8 .5 t 2 .3 ND
In144 RsaI V(EDLP)P 38 15 10.3 f 2 .9 4
In154 AM E(GRSS)L 2 7 6.9 t 2 .0 ND
In170 Alul E(GRSS)L 3 7 8.7 t 1 .5 ND
In171 RsaI L(WKIFH)Q 13 23 25 .4 f 8 .8 29
Y
In210 BstUI R(EDLP)G 31 32 29 .8 f 3 .3 20
In273 AIuI Q(REDLP)S 48 53 40.5 f 8.4 23
STableH . TGFSI-LAP Deletion Mutants
* TGFSI deletion mutant was expressed as pre-pro-TGFO1 by transfected COS-1 cells, and designated as A, followed by the numbers of the paired insertion mu-
tants used for its construction .
t In parentheses are the inserted amino acids derived from the mutant construction . The original codons and their positions after deletion are shown outside .
§ +, the immunoreactive TGFO1 in the supernatant from cells expressing TGFO1 deletion mutant was detected by immunoblot as shown in Fig . 4 A . -, not
detected .
110 l-LAP deletion mutant was expressed as pro region of TGFO1 independent of mature TGFOI, and identified as L, followed by the designation described for
TGFSI deletion mutants . Stop278 expresses wild-type /31-LAP .
I Detection of secreted /31-LAP deletion mutants as shown in Fig . 5 A . + and - indicate the same as described for
￿
marginal secretion .
** The cross-linking of the pro region dimer of TGFOI in the supernatants from cells transfected by Stop278 or S1-LAP deletion mutants with radioiodinated
TGFSI is described in Materials and Methods . After SDS-PAGE, the protein bands were excised and the amount of cross-linking was assessed by a y counter
(Fig . 6 B) . The results are represented as a percentage of the wild-type . Nonspecific binding was <20% . ND, not determined .
precursors . All other insertional mutants produced lower
levels of rTGFOI polypeptides . These mutants, except In210,
migrated at similar positions to wild-type, TGF01 precursors
on SDS-gels ; however, In2l0 migrated as a larger molecular
mass. Since we did restriction analysis as well as DNA se-
quencing, and did not find additional insertions beside the
introduced linker sequence, the retarded mobility of the high
molecular form of In2l0 may be due to differences in the
Figure2. Immunoblot of intracellular forms of pre-pro-TGFSI in-
sertion mutants from COS-1 cells. Transfected cells were collected
and processed as described in Materials and Methods . Cells (106 )
from wild-type or mutants were used for the immunoblot. The im-
munoblot was performed under reducing conditions and stained
with mature TGFSI-specific antibodies (antiTGF)31369_38 1 ; see
Fig. 3) . Alkaline phosphatase-conjugated protein A was used .
Markers are located to the left of the figure.
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disulfide folding pattern of this molecule . Note that for
In210, pro-TGFSI and its pro domain migrate similar to other
mutants on the reducing gels shown in Fig . 3 (C and D) .
Under reducing conditions of sample preparation (Fig . 3
C), the inununoblot probed with the same antibodies re-
vealed the existence of two forms of recombinant TGFSI
precursors in the supernatant from the wild-type transfec-
tant, a 44-56-kD band representing uncleaved pro-TGF01
(form a), and a 12-kD band corresponding to matureTGFSI
monomer (form c) (Gentry et al ., 1987 ; 1988) . Immunoreac-
tive mature or precursor forms ofTGF01 were not detected
in the supernatants from cells transfected with insertion mu-
tants In50, In154, and M170. 1n1 10 still made a small amount
of mature monomer . The other mutants appeared to secrete
lower levels of immunostained monomer than CDM8-TGFSI
(Fig . 3 C, band c) . To determine the degree of proteolytic
processing, immunoblots (Fig . 3 C) were scanned by den-
sitometry. The percentage of mature TGFSI (band c) rela-
tive to precursor (form a) generated by wild-type or its vari-
ous insertion mutants was similar (-40%) . Therefore, the
amount of mature 12-kD species is representative of the level
of secreted TGF,QI ; these values are listed in Table I using
100 for wild-type, mature TGFSI .
The amount of mature, monomeric TGFSI (Fig . 3 C) de-
tected by immunoblotting appeared greater than that of ma-
ture, dimeric TGFSI detected under nonreducing conditions,
especially for mutants In81, In85, and In144 (Fig . 3 B) .
Such an inconsistency may be due to a greater percentage
of mature, monomeric TGFSI forming disulfide cross-links
through Cys-33 of their precursors (Fig . 3 B) (Gentry et al .,
1988) . To test this possibility, immunoblots showing the ma-
ture dimers (form C) and larger disulfide aggregates of
TGFSI (form A) were scanned by densitometry (Fig . 3 B) .
After subtracting the appropriate background (i .e ., pCDM8),
83 1
TGFSI
deletion
mutants*
Position of
amino acids
deleted and inserted$ Secreted TGFOI§
S1-LAP
deletion
mutants 11 Secreted S1-Lapel
Cross-linking
(% of
wild-type)"
CDM8-TGFS l (+) Stop278 (+) 100
A40-50 E 39(GIP)G5 ' (-) L40-50 (+) 10
A50-81 R-(EHF)N82 (-) L50-81 (+) 0
A50-85 R5°(EDLP)D 86 (-) L50-85 (+) 0
A85-110 R"°(EDLP)V 11 ' (-) L85-110 (+) 12
A110-144 R"°(EDLP)P145 (-) L110-144 (-)
A139-170 E 139(GRSS)L170 (-)
A154-170 El 54(GRSS)L 170 (-) L154-170 (-)
A81-171 L80(WKIFH)Q 172 (_) L81-171 (-)
A85-210 R85(EDLP)G 211 (-) L85-210 (f) ND
A144-210 V'-(EDLP)G 2" (-) L144-210 (-)
A171-210 L"0(WKIDLP)G211 (-) L177-210 (-)
A210-273 R2 '0(EDLP)S 274 (-)Figure 3 . Immunoblots ofculture supernatants from transfected COS-1 cells expressing pre-pro-TGFO1 insertion mutants . Serum-free media
from transfected COS-1 cells were collected and processed as described in Materials and Methods . Conditioned, concentrated medium
from CHOcells (2 ul) whichexpress high levels of rTGF01 precursor (Gentry et al ., 1987) was used in these experiments as a standard ;
this is indicated above the immunoblots as TGFOI . Molecular size standards in kilodaltons are shown on the left of each panel . Results
are representative of three independent transfection experiments. (A) The diagram shown is a schematic representation of the structure
of pre-pro-TGFO1 polypeptide andthe sites of insertion mutations . Pro-TGF01, the pro region of TGFO1, and mature TGFOI are indicated
by a, b, and c, respectively. The asterisks denote N-linked glycosylation signals . Positions of the insertion mutants are designated by overly-
ing circles . Theshaded circles indicate reducedamounts ofTGFO1 precursor in the supernatant, andtheopen circles represent no detectable
amount ofthe precursors in the supernatant . (B) Medium from cells (1 ml) expressing the mutants was fractionated on a 12%SDSpolyacryl-
amide gel under nonreducing condition and stained for immunoreactive TGFO1 precursor using antiTGFO1369-3si . The identity of each
mutant is located above each lane . The letter Arepresents the disulfide aggregates expressed by the transfected COS-1 cells, andCdenotes
the mature TGF,Q1 dimer secreted . (C) Immunoblot of supernatants fractionated on 7.5-20% gradient SDS-polyacrylamide gels under
reducing condition . Blots were probed with same antibodies as described above . (D) Immunoblot ofsupernatants fractionated on 7.5-20%
gradient SDS-polyacrylamide gels . Blots were probed with antiTGF01225-236 antibodies .
the relative amount of mature, dimeric TGF(31 was then cal-
culated usingthe formula [C/(A + C)] x 100. This result is
listed in Table I as disulfide folding percentage .
The arbitrary value of disulfide folding percentage refers
to the relative amount of mature, dimeric TGFO1 present in
the culture medium . A value of 100% would mean that all
of pre-pro-TGF(31 is processed properly and that the mature
growth factor contains no disulfide formation with Cys-33
of thepro domain . Avalueof0% , on the other hand, would
mean that mature TGFRI was linked to Cys-33 of the larger
disulfide form . Wild-type, pre-pro-TGFOI transfectants pro-
ducedmature TGF/31, which represented -20% of the total
immunoreactive TGFOI (Fig . 3 B), a value in close agree-
ment with results from CHOcells expressing large amounts
of this growth factor (unpublished observations). Mutants
In81, In85, and In144 produced lower amounts of dimer
ranging from 4-6% . Mutants in the amino- and carboxyl-
portion of the TGFO1 pro domain (In40, In171, In210, and
In273) had virtually no effect on this Disulfide Folding Per-
centage (Table I), displaying values ranging from 20-30% .
These results indicate that regions surrounding residues 81,
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85, and 144 of the TGFO1 prodomainmay play an important
role in the disulfide modeling of mature TGF,61 .
Thecorresponding biological activities of wild-type, ma-
ture TGF0l andmutants were determined in a standard bio-
assay, using growth inhibition ofmink lung epithelial cells
(Table I) . Wild-type, mature TGFOI (pCDM8TGFO1) pro-
duced -70 ng/ml of TGFO, a value similar toaprevious re-
port (Brunner et al ., 1989) . This valuehas been normalized
to 100 for wild-type TGFO (Table I) . Mutants In50, In154,
and In170, which do not show immunoreactive TGFOI mon-
omers and dimers in their supernatants, had biological ac-
tivities similar to that produced by pCDM8 vector alone .
The amounts of biologically active TGFO correlated well
with the amount of mature TGFO1 dimers detected by im-
munological methods (see above; Fig . 3 B; Table I) .
Processed pro domains in the culture supernatants from
various transfected COS-1 cells were demonstrated by im-
munoblot analysis with antibodies against thepro region of
TGF,61 (Fig . 3 D) . Wild-type, precursor forms of TGF01
were apparent as two forms, both of which comigrated with
the rTGF01 precursor.A 44-56-kD band represents the un-
832processed pro-TGFO1 (form a), and the 30-42-kD species in-
dicates the pro region ofTGF01 (form b) . These results indi-
cate that both wild-type and mutant TGFO1 precursors
expressed by transfected COS-1 cells were properly pro-
cessed . Like the results shown in Fig . 3 (B and C), superna-
tants from cells transfected by mutants In50, Inl54, and
Inl70 did not demonstrate any immunoreactive TGFO1
precursors. The antibodies detected the existence of the pro
domain and minute amounts of mature monomeric TGF01
in the tissue culture supernatant from In110-transfected cells
(Fig . 3, C and D) .
Deletion Mutations in the TGF#l ProRegion
Abolished Secretion ofMatureGrowth Factor
To examine the role of the pro domain in secretion, a large
deletion ofthe TGFfl precursor wasmade using the two nat-
urally occurring SstlI restriction sites (Fig . 1) . The deletion
removes 162 amino acid residues in the pro domain includ-
ing all three glycosylation signals. When this deletion con-
struct was expressed in COS-1 cells, no secreted product was
detected . When cells were examined, an immunoreactive
protein corresponding to the size ofthe modified protein was
readily detected and was present at higher levels than normal
proTGFO1 (data not shown), suggesting that either glycosy-
lation or the pro domain was important in secretion (Sha et
al ., 1989) .
To examine the pro domain in more detail, deletion mu-
tants ofpre-pro-TGFO1 were transfected into COS-1 cells and
the secreted and cell-associated mutant proteins were de-
tected by immunoblotting using affinity-purified antipeptide
antiserum as shown in Fig . 4 . The results are summarized
in Table II . Immunoblots ofsupernatants probed with mature
(Fig . 4 A) or pro region-specific antibodies (data not shown)
from cells transfected with wild-type, pre-pro-TGFOI con-
firmed that TGFfl was expressed and secreted normally.
However, when any of the deletion mutants were expressed
in COS-1 cells, immunoblots of supernatants did not show
any corresponding immunoreactive TGFai precursor pro-
teins (Fig . 4 A) . These mutants of TGF01 were readily ex-
pressed in COS-1 cells, as demonstrated by immunoblotting
of cell extracts (Fig . 4B) . Under reducing conditions, these
affinity-purified antibodies against mature TGF,61 identified
the partially glycosylated TGF01 precursor (Sha et al ., 1989)
and the mature form of wild-type TGF(31 (see pCDM8-
TGF01 in the left two immunoblots), confirming that proteo-
lytic processing ofthe TGF0l precursor occurred intracellu-
larly. In cells transfected with the deletion mutants, mature
forms were not detected, while all mutant precursor forms
were expressed and appeared to accumulate to different ex-
tents . Previous work has demonstrated that proteolytic pro-
cessing of rTGFO1 precursor byCHO cells occurred in acidic
intracellular organelles (Sha et al ., 1989), where endopro-
teolytic cleavages at paired basic residues commonly occur
within acidic, clathrin-coated vesicles (Orci et al ., 1987) .
The results from our studies indicate that deletion mutations
within the TGF01 pro domain might either affect routing of
TGFQ1 precursor to the proper intracellular compartment
for proteolytic processing, or alternatively affect protein sta-
bility.
The mutant precursor forms migrated at shifted molecular
weights relative to wild-type, pre-pro-TGFO1 . Mutant pro-
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Figure 4. Determination of secreted and cell-associated precursor
forms ofTGFS1 deletion mutants . (A) Immunoblot ofsupernatants
from COS-1 cells transfected by deletion mutants of pre-pro-
TGF#1 . The A in each case represents the pre-pro-TGF/31 deletion
mutant ; numbers following the A represent insertion mutants used
for its construction . Supernatant from the various transfectants
were fractionated on 7.5-20% gradient SDS-polyacrylamide gels
under reducing conditions . The secreted protein was probed with
affinity-purified antiTGF01369-381 antibodies . The results have
been repeated three times and appear to be consistent . Marker pro-
teins are shown to the left . (B) Immunoblots oftransfected cells ex-
pressing pre-pro-TGFOl deletion mutants . Cells were collected as
described in Materials and Methods . For each mutant, 106 cells
were analyzed by immunoblotting under reducing conditions.
Affinity-purified anti-TGF01369-38, antibodies were used for these
immunoblots . Alkaline phosphatase-conjugated anti-rabbit IgG
was used for the immunoblots in the left two panels. Alkaline
phosphatase-conjugated Protein A was used for the right panel .
Markers are shown to the left.
teins would probably not migrate according to size since car-
bohydrate addition would not be uniform ; A50-85, A81-171,
A85-210, 0110-144, 0144-210, and A171-210 contain dele-
tions in N-linked carbohydrate addition sites .
Expression of01-LAPDeletionMutantsIndependent
ofMature TGF01
The pro region ofTGF01, when expressed independent ofthe
mature growth factor in recombinant systems, was able to
fold properly and be secreted from the transfected cells
(Gentry and Nash, 1990) . The insertion and deletion studies
indicated that disruption ofthe pro domain ofpre-pro-TGFO1
affected folding and secretion of mature TGFO1 . These re-
sults imply that information for protein conformation and/or
secretory transit ofpre-pro-TGFM are probably stored in the
pro domain, and that mature TGFf1 must somehow associ-
ate with this domain using covalent and/or noncovalent
bonds for proper folding and secretion from the cells.
833Deletion mutants were prepared in 01-LAP and placed
into the same expression vector (Table II) . The 01-LAP dele-
tion mutants were transfected into COS-1 cells, and tested
for their secretedpro region by immunoblotting with affinity-
purified antiserum against the pro domain (Fig. 5) . Un-
der reducing conditions (Fig. 5 A), cells transfected with
01-LAP (Stop278) produced a 30-42-kD immunoreactive
protein representing the wild-type, pro domain (Gentry and
Nash, 1990) . Interestingly, the pro regions in the superna-
tants from cells transfected with L40-50, L50-81, L50-85,
and L85-110 were also detected, suggesting that deletions in
the amino-terminal residues 40-110 of the pro region did not
abolish secretion of al-LAP However, mutants containing
deletions in residues 110-210 were not detected in the super-
natants fromCOS-1 cells . In cells expressing these mutants,
the levels of the mutant proteins were slightly higher than
that produced by wild-type 01-LAP (data not shown), sug-
gesting that these 01-LAP mutants may have protein secre-
tion defects . Mutant L85-210 reproducibly showed a small
amount of mutant protein secreted, while smaller deletion
mutants covering the same region gave no detectable, se-
creted pro region .
To demonstrate the different molecular sizes of wild-type
01-LAP (Stop278) and its deletion mutants, the culture su-
pernatants were treated with N-glycanase, and then further
analyzed by immunoblotting (Fig . 5 B) . Under reducing
condition, digestion with N-glycanase caused wild-type 01-
LAP (Stop278) to migrate as a sharp band of 26-28 kD,
which corresponds to the calculated molecular size of un-
glycosylated pro peptide (Brunner et al ., 1988 ; Sha et al.,
1989) . Similarly, the protein bands of 01-LAP deletion mu-
tants were shifted and had gel mobilities corresponding to
their sizes following deletion mutations .
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Figure 5 . Identification of 01-LAP deletion
mutants secreted from transfected COS-1
cells. A diagram showing the positions of
01-LAP deletion mutants is shown above.
The schematic representing the structure of
pre-pro-TGFS1 polypeptide is the same as
described for Fig . 3 . The solid bars repre-
sent the immunoreactive 01-LAP mutants
which were observed, open bars indicate no
detectable mutant proteins in the superna-
tants, and the cross-hatched bar shows mar-
ginally detectable 01-LAP in the culture
medium . L represents the deletion mutants
for 0I-LAP ; numbers that follow are identi-
cal to those shown in Fig . 4 . Supernatant
from each transfection was fractionated on
7.5-201 SDS-polyacrylamide gels and
probed with pro region-specific, affinity-
purified antiserum (antiTGF01225-236) un-
der reducing conditions (A) . Inununoblot
of N-glycanase-treated supernatants con-
taining 01-LAP deletion proteins is shown
in B. Digestion of the culture supernatants
with N-glycanase was performed as de-
scribed in Materials and Methods. Num-
bers shown below are the amino acids
deleted for each mutant .
Deletions in theAmino-terminal Pbrtion of01-LAP
Severely Reduce BindingtoMature TGFj31
Mutants that were able to secrete the 01-LAP pro regions
were examined for their abilities to generate functional
dimer forms by immunoblotting of culture supernatants un-
der nonreducing conditions (Fig . 6 A) . Consistent with a
previous report (Gentry and Nash, 1990), 01-LAP (Stop278)
produced a major protein band with a molecular mass
around 80 kD, and a minor band of 40-42 kD. The two pro-
tein species represent the dimer and monomer forms of 01-
LAP, respectively. The 01-LAP deletion mutants also ap-
peared to form dimers .
Previous studies reported thatthe independently expressed
01-LAP could associate with biologically active, mature
TGFO1 to form a latent complex in vitro (Gentry and Nash,
1990) . Removal of the amino-terminal sequence of the pro
region by protease treatment resulted in dissociation of the
latent complex (Lyons et al ., 1990) . We examined the associ-
ation of the 01-LAP deletion mutants with radioiodinated
matureTGF01 by cross-linking the two proteins (Gentry and
Nash, 1990) . Equivalent amounts of supernatants from cells
transfected with Stop278 or L40-50, L50-81, L50-85, and
L85-110 were incubated with radioiodinated TGFO1 and
subsequently treated with cross-linker (Fig . 6B) . The cross-
linked proteins were fractionated by nonreducing SDS-
PAGE followed by autoradiography (see Materials and Meth-
ods) . Incorporation of radioiodinated TGFSI into wild-type
and mutant ,f31-LAPs was then determined and expressed as
percentage of the wild-type (Table II) . When fl-LAP (Stop-
278) supernatant without cross-linker was included as a con-
trol, only the 24-kD radioiodinated, mature TGFO1 was de-
tected . After addition of cross-linker, a large aggregate of
834Figure 6. Detection of dimeric forms of01-LAP deletion mutants and subsequent cross-linking with radioiodinated, mature TGFf 1 . (A)
Supernatants from the (31-LAP deletion mutants were analyzed bySDS-PAGE on a 12% SDS polyacrylamide gel under nonreducing condi-
tions ; immunoreactive protein was identified by affinity-purified antiTGF01zz5-236 . Markers are shown to the left . (B) Culture medium
from the control transfectants or from cells expressing 01-LAP deletion mutants was first normalized and then incubated with radioiodi-
nated, mature TGFO1 and cross-linked with bis(sulfosuccinimidyl) suberate as described in Materials and Methods. Cross-linked TGFO1
complexes were fractionated on 7.5% SDS-polyacrylamide gel followed by autoradiography . The + and - at the bottom of the figure
indicate whether or not cross-linker was added . -y-Spectroscopy counts of each mutant are shown in Table 11 .
cross-linked TGFO1 was observed at the top of the gel (>200
kD) . A limited amount of cross-linked TGFO1 complex was
observed in the lane marked Stop278. This lane contains
wild-type ,131-LAP protein which efficiently binds to mature
TGFO1 and prevents excessive aggregation . Cross-linking
01-LAP (Stop278) generated a 100-110-kD species which
represented 47% of the input TGF/31 radioactivity . No such
protein was detected in the pCDM8medium . This 100-110-
kD species represents the cross-linked complex containing
one dimer ofthe pro domain (80kD) and one matureTGFO1
dimer (24 kD) (Gentry and Nash, 1990) .
Deletion mutations in the amino-terminal part of the pro
region affected formation of the cross-linked complex (Fig .
6 B) . Mutant L40-50 and L85-110 reduced the amount of
the cross-linked complex formed giving 10 and 12% ofwild-
type 01-LAP (Stop278), respectively. Mutants L50-81 and
L50-85 did not form cross-linked complexes . The complex
of L85-110 had a lower molecular size compared with wild-
type 01-LAP (Stop278), probably from its 25 residue dele-
tion . The mobility shift of L40-50 was not observed under
these conditions due to its smaller deletion . A minor cross-
linked species (45 kD) was observed in all mutants and
pCDM8 supernatants .
01-LAP (Stop278) and the four X31-LAP deletion mutants
were also tested by bioassay for their abilities to regulate the
growth inhibition activity of the mature TGF#1 . Consistent
with a previous report (Gentry and Nash, 1990), 01-LAP
(Stop278) medium inhibited theTGFO1 bioactivity, whereas
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L40-50 and L85-110 had 2-4% the activity of Stop278, and
L50-81 and L50-85 were not inhibitory (data not shown) .
These results indicate the importance of the amino-terminal
region (residue 50-85) of01-LAP in latent complex forma-
tion . Although this region contains the first glycosylation
signal, one of the deletion mutants of 01-LAP (L50-85)
that lacks this site was readily secreted, suggesting that this
N-linked oligosaccharide addition site is not essential for
secretory transport of,81-LAP The carboxyl-terminal halfof
/31-LAP, on the other hand, appears to contain sequences that
are essential for secretory exit of 01-LAP and pre-pro-TGFO1 .
Discussion
TGFO1 possesses multiple functional properties that affect
cell growth and differentiation (Robert and Sporn, 1990) .
TGFO1 is synthesized as a precursor, which subsequently
undergoes extensive posttranslational processing events for
mature TGFal, which is secreted (Derynck et al ., 1985 ;
Gentry et al ., 1988 ; Brunner et al ., 1988) . The secreted
TGFO1 exists as a biologically inactive or latent form that
is not able to bind to its cell surface receptors (Lawrence
et al ., 1985) . Latency results from the binding of mature
growth factor to a dimer of its own pro region, termed 01-
LAP (Gentry et al ., 1987; Miyazono et al., 1988 ; Wakefield
et al ., 1988 ; Gentry and Nash, 1990) . Since the presence of
TGFO1 receptors is universal (Wakefield et al ., 1987), latent
complex formation and its activation through an unknown
835Figure 7 (A) Sequence homology of human TGFO1, 02, and 03 .
The diagram represents the structure ofpre-pro-TGFOL Glycosyla-
tional signals and sites of proteolytic processing are shown as aster-
isks and arrows, respectively . The blackened areas indicate the con-
served amino acids between human TGFO1, (32, and /33 . (B)
Schematic representation of functionally important regions in pre-
pro-TGF#1 . The blackened areas indicate that mutations in these
regions abolished detection of secreted TGF01 precursor. The
shaded areas show that mutations in these regions reduced the lev-
els of TGF/31 precursor detected in the culture supernatants . Inser-
tions in areas represented by diagonal lines resulted in misfolded
pro and matureTGFOL (C) Schematic representation of /31-LAP
and the various deletion mutants . The blackened areas are impor-
tant for secretion of 0l-LAP The vertical lined areas represent
regions important for binding mature TGFO1 to form the latent
complex . The closely packed vertical lines identify regions result-
ing in (31-LAP mutants which no longer bind mature TGFOL In
each of the above diagrams, the position of the sequences has been
aligned for direct comparison .
mechanism must be an important part of the control of
TGFO1 function . The pro domain also aids in proper folding
ofthe mature growth factor intracellularly (Gray and Mason,
1990) . Despite these known functional roles, very little is
known about structure/function relationships of the pro re-
gion . Using mutants generated by linker insertion, we have
demonstrated that the structural integrity of the pro region
is required for export of mature TGFO 1 . In addition, we have
defined several regions in the pro domain that are important
in the folding, stability, secretion, and latent complex forma-
tion of TGFO1 .
An illustration demonstrating the results from our experi-
ments and how these results relate to the sequence homology
ofhuman TGFOI, 02, or 03 is shown in Fig . 7. Linker inser-
tion mutagenesis at three sites in the pro domain of simian
TGFf1 (amino acids 50, 154, and 170) abolished detection
of all three forms of mutant TGF/31 precursor in culture su-
pernatants, whereas insertion in other regions resulted in di-
minished levels ofthe secreted precursor toTGFO1 (Fig . 3) .
Deletion mutations have provided similar results. All dele-
tion mutants, even the mutant lacking 10 amino acids, were
not secreted (Fig . 4) . This does not appear to be the result of
decreased protein expression, since mutant proteins were ex-
pressed intracellularly at levels comparable to wild-type,
pre-pro-TGFOI (Fig . 2) . Previous work has indicated that the
independently expressed mature TGFO1 was not properly
folded and/or secreted from transformed cells unless coex-
pressed with its pro domain (Gray and Mason, 1990) . To-
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gether with our results, we speculate that either the primary
sequence ofthe pro domain and/or its resultant conformation
is essential in secretory export of mature TGFO1 .
Does the amino acid sequence of the inserted linker play
a specific role in the degradation of the mutant TGFO1
precursor? Table I lists the four different linker sequences
which were placed into the precursor of TGF,Ql . In40 and
In273 resulted in the insertion of an Arg residue, an amino
acid sensitive to hydrolysis by plasmin and many cellular
proteases . In154 and In170 also contain insertions that result
in the placement of specific Arg residues . Why then are In40
and In273 stable to this insertion and In154 and In170 unsta-
ble? Perhaps insertions at the ends of the molecule (In40 and
In273) will not affect the biological activity of 01-LAP.
Placement of this linker sequence toward the middle of the
molecule (Inl54 and M170) somehow disrupts the normal
functional properties of ,QI-LAP, either through the inclusion
of a positive charge or through the addition of an amino acid
that is recognized by cellular proteases . SDS-gel electropho-
resis of these mutant TGF,Q1 molecules did not reveal the
presence of any degraded protein precursor either in the cell
or in the culturemedium (Figs . 2 and 3) . Insertions after an
Arg residue for In50 may have resulted in degraded protein
by providing a hydrolyzable "kink" in the precursor polypep-
tide chain, resulting in degradation . However, this seems un-
likely, since In85, InlIO, and In210 also contain insertions
after Arg residues and produce mutants that were readily de-
tected in the culture medium (Fig . 3) . Moreover, In50 pro-
duced intracellular levels of precursor similar or greater to
wild-type TGFOI with no detectable degradation products
(Fig . 2) . We have yet to test the effects of two different four
amino acid insertions at the same position in the TGFRI
precursor.
Independently expressed (31-LAPS lacking amino-terminal
sequences 40-110 were readily secreted from cells and these
mutants appeared to exist as dimeric structures. By contrast,
(31-LAPs with mutations between residues 110 and 210 were
apparently not secreted (Fig . 5) . Cross-linking studies and
bioassays indicated that the secreted /31-LAP deletion mu-
tants interacted marginally with mature TGF01 (L40-50 and
L85-110) or not at all (L50-81 and L50-85), suggesting an
importance of these deleted sequences in latent complex
formation (Fig . 6) . These results indicate that amino acid
residues 50-85 of /31-LAP are probably involved in main-
taining the structure of the latent complex . Residues 40-50
and 85-110 may only be superficially involved in binding
mature TGFOL
A similar suggestion has recently beenmade looking at the
latent form of rTGFO1 precursor after plasmin digestion . In
those studies, activation ofthe latent complex occurred after
removal of the amino-terminal portion of the pro domain af-
ter plasmin digestion ; these results suggest that this region
of al-LAP is important for stabilizing the latent complex
(Lyons et al., 1990) . Analysis of the TGF01 precursor se-
quence indicates that residues 40-60 are the largest con-
served continuous sequence of the pro domain in all three
TGFas, and appear to be rich in basic residues . It is likely
that residues 40-60may be involved in the binding ofTGF/31
through electrostatic interactions . This interaction could
stabilize the entire protein complex, which is essential to
form the latent complex . Residues 110-210 of /31-LAP may
also be involved in the protein interaction ; no such pro re-
836gion mutants were secreted from COS-1 cells (Fig. 5). Based
on these results, it appears that latent complex formation is
required for proper secretory exit of the mature growth fac-
tor or its stability. In deletions that eliminate residues
40-110, the /31-LAPS were still folded into a transportable
structure. However, when expressed as pre-pro-TGFal, these
mutants were not detected as secreted forms. We presume
that the mature growth factor was unable to associate with
the mutant pro domain and resulted in an altered conforma-
tion that could affect the mature TGF01 stability or its ex-
port. Insertion mutant In50, which did not show secreted
TGF01, might also fail to form the latent complex, resulting
in a defect in protein secretion (Fig. 3) .
The region corresponding to residues 110-210 of pre-pro-
TGF01 appears to be essential in export ofthe mature growth
factor (Figs. 4 and 5). Mutants In154and In170had secretion
or stability defects when expressed both as pre-pro-TGFOI
(Fig. 3) and al-LAPS (data not shown) . Regions containing
amino acids 154 and 170 appear to lie in strictly conserved
regions amongthe sequenced humanTGF0s(Fig. 7) . TGF01
precursor polypeptides could not be detected in COS-1 su-
pernatants when the linker sequence GRSS was inserted in
these regions. Presumably this region of the protein could
form secondary structures which may be essential for proper
folding ofthe pro domain and may be used for secretory exit.
One of the best known examples concerning domains in-
volved in protein transport has come from studies ofintracel-
lulartransport of vesicular stomatitis virus (VSV) G protein
(Roseand Bergmann, 1983 ; Dams et al ., 1987, 1988). Using
in vitro mutagenesis of the VSV G cDNA, these researchers
found that deletion of the carboxyl-domain, a domain lying
in the cellular cytoplasm, had profound effects on secretion
ofthe VSV G protein without altering the whole protein con-
formation, indicating that this domain must fulfill structural
requirements for intracellular routing independent of other
protein domains. In addition, assembly ofthe VSV G protein
into a trimer was required for normal transport. Experi-
ments to determine the cell-associated mutant TGFO1 pre-
cursors by immunoblotting under nonreducing conditions
showed that dimers ofIn50, In54, and In170, which were not
secreted, were readily identified intracellularly along with
wild-type, pre-pro-TGFOI (data not shown) indicating that
formation of a dimer was not a prerequisite for transport of
TGF01.
The pro domain ofTGF01 may function analogously to the
pro domain of somatostatin, a domain that is important for
secretion ofthe mature somatostatin . This neuropeptide has
a structure analogous to pre-pro-TGFOI consisting ofa signal
peptide followed by a pro peptide and the mature hormone
(Hobart et al., 1980). The pre-pro sequence, when fused to
ci-globin mediated the cytoplasmic protein to be secreted in
a regulatory pathway. In contrast, if a-globin was fused to
a signal peptide alone, it was translocated to ER, but in the
absence of the pro domain it was rapidly degraded, suggest-
ing that the pro peptide protected nascent precursor from
protease attack, probably by enhancing its folding and facili-
tating efficient export (Stoller and Shields, 1989). It is likely
that mutation in the pro region of TGF01 resulted in misfold-
ing of the newly synthesized precursor, which was recog-
nized and degraded by intracellular enzymes. To confirm
this, additional experiments using antibodies that immuno-
precipitate wild-type and mutant TGFO1 precursors to deter-
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mine the kinetics of intracellular routing of these TGF01
forms will be necessary to provide important information
about their eventual fate.
N-linked oligosaccharides are often crucial in promoting
export of protein. However, this requirement for carbohy-
drate in transport of membrane or secretory proteins is not
universal and is highly protein specific as well as cell specific
(reviewed by Olden et al ., 1982). Using glycosylational in-
hibitors, we have determined that glycosylation and its matu-
ration state affected secretion of rTGF01 precursors from
CHO cells (Sha et al., 1989). The effects ofoligosaccharides
on protein secretion most likely results from incorrect pro-
tein folding and protein instability as reported by many in-
vestigators (Graft et al ., 1987; Slieker et al ., 1986 ; Dams et
al., 1988) . Initially, when we designed the deletion mutants,
we hoped to see some correlation with carbohydrate sites
and secretion. Deletion mutants lacking each of the three
glycosylational signals in the pro portion of pre-pro-TGFOI
were prepared to assess the role of the individual oligosac-
charides on protein secretion (Fig. 1). However, all deletion
mutants ofpre-pro-TGFOI were not secreted (Fig. 4 A) . De-
letion mutant A81-171 which lacks the first and second
glycosylational signals was partially degraded in the COS-1
cells (Fig. 4 B), indicating that these carbohydrates may
be important for protein stability. The first carbohydrate
moiety does not appear to play a role in the secretion of
(31-LAP, since such mutants thatdelete this N-linked addition
site were readily observed in the culture medium (Fig. 6) .
Selective removal of glycosylational sites without disrupting
sequences on either side of this signal using site-directed
mutagenesis are in progress and should allow for proper
evaluation ofthe role of individual oligosaccharides in proper
folding and secretion of mature TGF01 and (31-LAP
Insertion mutations which reduced transport did not ap-
parently affect proteolytic processing of mature TGF01, sug-
gesting that the dibasic cleavage site before the amino-
terminus of mature TGF01 is readily exposed on the protein
even with altered folding. The intracellular forms ofthe dele-
tion mutants which had defects in secretion were not
processed properly. We suggest that the misfolded mutant
proteins were probably not transferred to the Golgi appara-
tus where the proteolytic processing of protein precursors
begins (Steiner et al., 1984). Dibasic cleavage sites releasing
the mature portion of TGF01 are usually not accessible to
protease attack in wild-type, pre-pro-TGFO1. Insertion mu-
tation in region 110 secreted the pro piece ofTGF(61 but very
little mature TGF#1. Antibodies against mature TGFO1 de-
tected the existence ofmutant precursor intracellularly, sug-
gesting that the pro domain affected proper folding ofthe ma-
ture TGFM . The misfolded mutant was probably degraded
during secretion.
Unlike most tissue culture cells which secrete mature
TGFOI and the pro form together as a latent complex, the
transfected CHO and COS-1 cellswere unable to completely
process TGF01 precursor (pro-TGF01), and secreted all
three forms of rTGFO1. Furthermore, these transformed cells
released a disulfide aggregate of rTGFal precursor, where
the pro domain is disulfide linked to mature TGFOI through
Cys-33 and an unknown Cys residue in the mature region
(Gentry et al., 1987, 1988; Brunner et al., 1989; Lyons et
al., 1990). Latent TGFSI is secreted from tissue culture cells
as a tri-peptide complex containing a cysteine-rich "binding
837protein7, the pro domain of TGFO1, and mature TGF01
(Miyazono et al., 1988; Wakefield et al., 1988 ; Kanazaki et
al., 1990; Tsuji et al ., 1990). Thus, it appears that secretion
of this larger disulfide-linked form may represent an expres-
sion artifact. From our insertional mutation studies, we
found that mutations in amino acid 81, 85, and 144 of the
pro domain resulted in a large amount ofdisulfide aggregate,
further indicating that the pro domain plays an important
role in the proper folding of mature TGFO1.
In summary, site-specific insertion and deletion mutagen-
esis of the pro domain of pre-pro-TGFOI indicate that the
structural integrity of the pro region is required in secretary
transport of TGFOI precursors. Additionally, our results
highlight the amino-terminal region of the pro domain as be-
ing important for interaction with the mature TGFOI and in-
dicated that this interaction must be maintained for latent
complex formation and protein secretion. Finally, a compar-
ison of the amino acid sequences of the pro domains from
TGFO1, /32, and 03 indicate that, even though these domains
share <50% amino acid identity, functionally important
regions identified by insertional mutagenesis are strictly
conserved among them. The sequence homology in these
regions presumably reflects their biological importance.
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